|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 154.61 USD | +0.33% |
|
-2.66% | -21.32% |
| 06-17 | Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating | MT |
| 06-11 | IQVIA Launches New AI Agents for Life Sciences and Healthcare | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IQVIA HOLDINGS INC. | Other Biotechnology & Medical Research | +0.33% | -2.66% | -21.32% | -27.36% | +11.94% | 26.75B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IQV Stock
- Charts Iqvia Holdings Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition